Stay updated on Cabozantinib in Advanced Solid Malignancies Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.

Latest updates to the Cabozantinib in Advanced Solid Malignancies Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now shows Revision: v3.6.6, replacing v3.6.5, indicating a minor platform update. It does not change the study data or visible content on the page.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, indicating a software/template update to the ClinicalTrials.gov page. This change does not alter any study details, eligibility criteria, or reported results.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the prior Revision: v3.6.3. This appears to be a minor metadata/version update reflecting an updated page build.SummaryDifference0.1%

- Check77 days agoChange DetectedThe page now shows Revision: v3.6.3, replacing Revision: v3.6.2. This indicates a minor version update to the page rendering rather than changes to the study information.SummaryDifference0.1%

- Check84 days agoChange DetectedThe site revision was updated from v3.6.0 to v3.6.2, indicating a deployment of updates to the ClinicalTrials.gov interface or backend. The change does not modify the study content or data displayed on the page.SummaryDifference0.1%

- Check98 days agoChange DetectedNew recruitment status indicates that the study is no longer looking for participants, and the page gains new help/navigation links such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment heading formatting was adjusted, and a site revision note Revision: v3.6.0 was added.SummaryDifference0.5%

Stay in the know with updates to Cabozantinib in Advanced Solid Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Solid Malignancies Clinical Trial page.